AGL 40.00 No Change ▼ 0.00 (0%)
AIRLINK 129.06 Decreased By ▼ -0.47 (-0.36%)
BOP 6.75 Increased By ▲ 0.07 (1.05%)
CNERGY 4.49 Decreased By ▼ -0.14 (-3.02%)
DCL 8.55 Decreased By ▼ -0.39 (-4.36%)
DFML 40.82 Decreased By ▼ -0.87 (-2.09%)
DGKC 80.96 Decreased By ▼ -2.81 (-3.35%)
FCCL 32.77 No Change ▼ 0.00 (0%)
FFBL 74.43 Decreased By ▼ -1.04 (-1.38%)
FFL 11.74 Increased By ▲ 0.27 (2.35%)
HUBC 109.58 Decreased By ▼ -0.97 (-0.88%)
HUMNL 13.75 Decreased By ▼ -0.81 (-5.56%)
KEL 5.31 Decreased By ▼ -0.08 (-1.48%)
KOSM 7.72 Decreased By ▼ -0.68 (-8.1%)
MLCF 38.60 Decreased By ▼ -1.19 (-2.99%)
NBP 63.51 Increased By ▲ 3.22 (5.34%)
OGDC 194.69 Decreased By ▼ -4.97 (-2.49%)
PAEL 25.71 Decreased By ▼ -0.94 (-3.53%)
PIBTL 7.39 Decreased By ▼ -0.27 (-3.52%)
PPL 155.45 Decreased By ▼ -2.47 (-1.56%)
PRL 25.79 Decreased By ▼ -0.94 (-3.52%)
PTC 17.50 Decreased By ▼ -0.96 (-5.2%)
SEARL 78.65 Decreased By ▼ -3.79 (-4.6%)
TELE 7.86 Decreased By ▼ -0.45 (-5.42%)
TOMCL 33.73 Decreased By ▼ -0.78 (-2.26%)
TPLP 8.40 Decreased By ▼ -0.66 (-7.28%)
TREET 16.27 Decreased By ▼ -1.20 (-6.87%)
TRG 58.22 Decreased By ▼ -3.10 (-5.06%)
UNITY 27.49 Increased By ▲ 0.06 (0.22%)
WTL 1.39 Increased By ▲ 0.01 (0.72%)
BR100 10,445 Increased By 38.5 (0.37%)
BR30 31,189 Decreased By -523.9 (-1.65%)
KSE100 97,798 Increased By 469.8 (0.48%)
KSE30 30,481 Increased By 288.3 (0.95%)
Editorials

Renowned cancer-fighting protein can also boost cancer growth: study

A new study has challenged the fact that a widely known human protein that was previously thought to help fight can
Published February 2, 2019 Updated February 7, 2019

A new study has challenged the fact that a widely known human protein that was previously thought to help fight cancer can even boost the tumor growth too.

Scientists from University of California San Diego have carried out a new study challenging the description of the human protein ‘p53’ that is renowned for its cancer-fighting abilities, leading to its popular title as ‘the guardian of the genome’.

“The widely accepted idea is that p53 suppresses cancer, but in our study we would argue against that. In some cancers it would have the opposite effect by promoting cancer,” said researcher Yang Xu.

Smart cancer pills track patients with tiny sensors in their medicines

Studying the ‘wild type’ version of p53 – WTp53 – that is present widely in nature, the team found evidences that in some cases, the protein instead promotes tumors rather than suppressing them. The finding explains the established enigma that though p53 is mutated in over 50% of all human cancers, it is not frequently mutated in some cancers such as liver cancer.

Over four years research on liver cancer showed that WTp53 stimulates tumor growth by enhancing cancer metabolism. The key, as the researchers explain, is a protein called PUMA, which works inside the energy hub of cells – the mitochondria.

They found that at appropriate levels, PUMA disrupts normal function of mitochondria and causes a switch from oxidative phosphorylation – process for efficient energy production in cells – to glycolysis – alternative energy path that helps boost cancer metabolism.

“It’s actually the same function but playing exactly the opposite role in two different contexts,” said Xu publishing their study in the journal Cancer Cell.

Xu notified that the research provides a warning for cancer drug discovery. Drug therapies designed to improve p53’s function in cancer patient might be inadvertently causing an opposite effect, wrote Science Daily.

Copyright Business Recorder, 2019

Comments

Comments are closed.